scientific program • symposia - American Society for Reproductive ...

POLYCYSTIC OVARY SYNDROME
P-65 ENDOTHELIAL FUNCTION IS IMPAIRED IN POLYCYSTIC
OVARIAN SYNDROME AND CAN BE IMPROVED WITH EXERCISE
TRAINING.
V. S. Sprung, D. J. Cuthbertson, C. J. A. Pugh, N. F. Aziz, D. J. Green,
H. Jones. Research Institute for Sport and Exercise Sciences,
Liverpool John Moores University, Liverpool, Merseyside, United
Kingdom; Department of Obesity & Endocrinology, University
Hospital Aintree, Liverpool, Merseyside, United Kingdom;
Department of Gynaecology, Liverpool Women’s Hospital,
Liverpool, Merseyside, United Kingdom.
P-66 ANDROGEN EXCESS IN WOMEN WITH PCOS
UNDERLIES AN ADVERSE METABOLIC PROFILE.
E. T. Wang, C.-N. Kao, H. G. Huddleston, M. I. Cedars. Obstetrics
Gynecology & Reproductive Sciences, University of California San
Francisco, San Francisco, CA.
P-67 RACIAL DIFFERENCE IN INSULIN RESISTANCE BETWEEN
AFRICAN-AMERICAN AND CAUCASIAN WOMEN WITH
POLYCYSTIC OVARY SYNDROME.
K. I. Cheang1 , R. S. Lucidi2 , J.-P. Baillargeon3 , P. A. Essah4 , J. E. Nestler4 .
1Pharmacotherapy & Outcomes Science, Virginia Commonwealth
University, Richmond, VA; 2Obstetrics and Gynecology, Virginia
Commonwealth University, Richmond, VA; 3Departement de
Medecine, Universite de Sherbrooke, Sherbrooke, QC, Canada;
4Internal Medicine, Virginia Commonwealth University, Richmond,
VA.
P-68 TEARLY METABOLIC AND ENDOCRINE PERTURBATIONS
IN PRE- OR PERIPUBERTAL GIRLS WITH A FIRST DEGREE RELATIVE
WITH POLYCYSTIC OVARY SYNDROME.
A. Trottier 1 , M.-C. Battista 1 , A. Carpentier 1 , J. Simoneau-Roy 1 , D.
Geller 2 , J.-P. Baillargeon 1 . 1 Division of Endocrinology/Department
of Medicine, Université de Sherbrooke, Sherbrooke, QC, Canada;
2 Division of Pediatrics, David Geffen School of Medicine, University
of California in Los Angeles (UCLA), Los Angeles, CA.
P-69 TRIGLYCERIDE TO HIGH-DENSITY LIPOPROTEIN
CHOLESTEROL RATIO AS A PREDICTOR OF INSULIN RESISTANCE
IN WOMEN WITH POLYCYSTIC OVARY SYNDROME (PCOS).
A. Ketefian 1,2 , M. Amin 1,2 , D. Manning 1 , R. Azziz 3 , M. Pisarska 1,2 , C.
Alexander 1,2 . 1 Obstetrics and Gynecology, Cedars-Sinai Medical
Center, Los Angeles, CA; 2 Obstetrics and Gynecology, University of
California, Los Angeles, Los Angeles, CA; 3 Obstetrics, Gynecology,
and Medicine, Georgia Health Sciences University, Augusta, GA.
P-70 METFORMIN ALONE OR COMBINED WITH
CLOMIPHENE CITRATE IN WOMEN WITH POLYCYSTIC OVARY
SYNDROME AND INFERTILITY: SYSTEMATIC REVIEW.
T. Moresco, V. Genro, C. Schmitz, C. Souza, J. Cunha-Filho. Serviço
de Ginecologia e Obstetrícia, Hospital de Clínicas de Porto Alegre,
Porto Alegre, Rio Grande do Sul, Brazil.
P-71 EFFICACY OF VAGINAL PROGESTERONE
INSERTS (Endometrin®) COMPARED TO INTRAMUSCULAR
PROGESTERONE IN OIL FOR LUTEAL SUPPORT IN PCOS
PATIENTS.
A. Beltsos 1 , M. Sanchez 2 , K. Doody 3 , M. Bush 4 , J. Scobey 5 . 1 Fertility
Centers of Illinois, Chicago, IL; 2 Women Medical Research Group,
LLC, Clearwater, FL; 3 Center for Assisted Reproduction, Bedford, TX;
4 Conceptions Reproductive Associates of Colorado, Littleton, CO;
5 Ferring Pharmaceuticals Inc., Parsippany, NJ.
P-72 GnRH ANTAGONIST PROTOCOL – DOES IT REDUCE
THE RISK OF OVARIAN HYPERSTIMULATION IN WOMEN WITH
PCOS UNDERGOING IVF AS COMPARED TO LONG AGONIST
PROTOCOL: A SYSTEMATIC REVIEW AND META-ANALYSIS.
J. Pundir, S. K. Sunkara, T. El-Toukhy, Y. Khalaf. Guy’s and St Thomas’
NHS Foundation Trust, London, United Kingdom.
POSTER PRESENTATIONS
142
P-73 ADIPOSITY, INSULIN INDICES, AND ADIPOKINE
PROFILE THROUGH THE PUBERTAL TRANSITION IN OVERWEIGHT
LATINA ADOLESCENTS WITH AND WITHOUT POLYCYSTIC
OVARIAN SYNDROME (PCOS).
B. J. Rudick 1 , G. Wen 2 , F. Stanczyk 1 , M. J. Weigensberg 2 , M. I. Goran 2 ,
J. N. Davis 2 . 1 Obstetrics and Gynecology, Division of Reproductive
Endocrinology and Infertility, University of Southern California, Los
Angeles, CA; 2 Department of Preventative Medicine, University of
Southern California, Los Angeles, CA.
P-74 ABNORMAL EXPRESSION OF GROWTH
DIFFERENTIATION FACTOR 9 (GDF9) AND BONE
MORPHOGENETIC PROTEIN 15 (BMP15) IN OVARIAN TISSUES
FROM UNSTIMULATED POLYCYSTIC OVARIES.
L.-N. Wei, X.-Y. Liang. Center for Reproductive Medicine, The
Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou,
Guangdong, China.
P-75 THE RELATIONSHIP BETWEEN MYOSTATIN, ABDOMINAL
OBESITY, ANDROGEN AND FOLLISTATIN IN WOMEN WITH
POLYCYSTIC OVARY SYNDROME.
M.-J. Chen 1 , D.-S. Han 3 , Y.-S. Yang 1 , W.-S. Yang 2 , H.-N. Ho 1 . 1 Obstetrics
and Gynecology, National Taiwan University Hospital, Taipei, Taiwan;
2 Internal Medicine, National Taiwan University Hospital, Taipei,
Taiwan; 3 Physical Medicine and Rehabilitation, National Taiwan
University Hospital, Taipei, Taiwan.
P-76 ENDOMETRIAL THICKNESS IN ANOVULATORY WOMEN
OF REPRODUCTIVE AGE.
M. Hsu, S. Huang, C.-R. Tzeng, C.-H. Chen, C.-W. Wang, C.-S. Hsu.
Department of Obstetrics and Gynecology, Wan Fang Hospital,
Taipei Medical University, Taipei, Taiwan; Department of Obstetrics
and Gynecology, Taipei Medical University Hospital, Taipei Medical
University, Taipei, Taiwan.
P-77 COMPARISON OF ENDOMETRIAL HISTOLOGY AND
CLINICAL FEATURES IN LEAN AND OBESE KOREAN WOMEN
WITH POLYCYSTIC OVARY SYNDROME.
J. Park, S. Lim, J. Bae, J. Kim, J. Rhee. Obstetrics and Gynecology,
Keimyung University, Daegu, Korea.
P-78 GONADOTROPIN STIMULATION OF THE PATIENT WITH
POLYCYSTIC OVARIAN SYNDROME: A COMPARISON OF ORAL
CONTRACEPTIVE PILL/DUAL SUPPRESSION LUPRON PROTOCOL
VERSUS ORAL CONTRACEPTIVE/ANTAGONIST PROTOCOL.
A. Aelion Brauer, E. Mok-Lin, R. Elias, D. Goldschlag, Z. Rosenwaks.
The Ronald O. Perelman and Claudia Cohen Center for
Reproductive Medicine, New York, NY.
P-79 INCREASED THECA CELL ANDROGEN RESPONSE TO
hCG STIMULATION WITH FSH ADMINISTRATION IN WOMEN
WITH POLYCYSTIC OVARY SYNDROME.
S. S. Chuan, M. A. Rosencrantz, H. I. Su, R. Shayya, A. Haggan,
R. J. Chang. Reproductive Medicine, Division of Reproductive
Endocrinology and Infertility, UCSD, La Jolla, CA.
P-80 EXPRESSION OF DNA REPAIR GENES IN BLASTOCYSTS
DERIVED FROM INFERTILE WOMEN WITH PCOS.
A. Streiby 1 , B. McCallie 1 , D. A. Minjarez 2 , M. Katz-Jaffe 2 . 1 National
Foundation for Fertility Research, Lone Tree, CO; 1 Colorado Center
for Reproductive Medicine, Lone Tree, CO.
P-81 EVIDENCE OF ENDOTHELIAL DYSFUNCTION IN A RAT
MODEL OF PCOS: INCREASED CONSTRICTOR PROSTAGLANDIN
ACTIVITY, REVERSIBLE THROUGH COX INHIBITION.
J. L. Keller 1 , M. Mandala 1,2 , P. Casson 1 , G. Osol 1 . 1 Obstetrics,
Gynecology and Reproductive Sciences, University of Vermont,
Burlington, VT; 2 University of Calabria, Rende, CS, Italy.
__________________________________________________________